Cabaletta Bio
CABA
CABA
61 hedge funds and large institutions have $183M invested in Cabaletta Bio in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
13% more funds holding
Funds holding: 54 → 61 (+7)
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
Holders
61
Holding in Top 10
1
Calls
$981K
Puts
$185K
Top Buyers
| 1 | +$26.1M | |
| 2 | +$17.5M | |
| 3 | +$11.6M | |
| 4 |
CC
Commodore Capital
New York
|
+$9.35M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.56M |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$3.35M | |
| 3 | -$3.23M | |
| 4 |
EP
Eversept Partners
New York
|
-$2.57M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$2.15M |